Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Prepaid Assets (2016 - 2026)

Amphastar Pharmaceuticals has reported Prepaid Assets over the past 13 years, most recently at $13.2 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 27.79% year-over-year to $13.2 million; the TTM value through Dec 2025 reached $13.2 million, down 27.79%, while the annual FY2025 figure was $13.2 million, 27.79% down from the prior year.
  • Prepaid Assets for Q4 2025 was $13.2 million at Amphastar Pharmaceuticals, down from $26.0 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $26.0 million in Q3 2025 and troughed at $5.9 million in Q2 2023.
  • A 5-year average of $10.6 million and a median of $7.7 million in 2021 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: dropped 29.41% in 2021 and later soared 186.04% in 2024.
  • Year by year, Prepaid Assets stood at $7.3 million in 2021, then rose by 3.97% to $7.6 million in 2022, then increased by 19.75% to $9.1 million in 2023, then soared by 101.1% to $18.2 million in 2024, then decreased by 27.79% to $13.2 million in 2025.
  • Business Quant data shows Prepaid Assets for AMPH at $13.2 million in Q4 2025, $26.0 million in Q3 2025, and $20.3 million in Q2 2025.